-
(149-17) Phase II, Double-Blind, Randomized Trial Of AVOVA-1 (Autologous Dendritic
Cells Loaded With Autologous Tumor Associated Antigens) Vs. Autologous
Peripheral Blood Mononuclear Cells (MC) In Patients With Stage III Or
IV Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma
After Primary Therapy (Phase 2 clinical trial, appropriate for patients with ovarian cancer.)
-
(157-17) FID-007 in Treating Participants With Advanced Solid Tumors (Phase 1 clinical trial, appropriate for patients with advanced solid
malignancies.)
- (167-17) Caris ctDNA Validation Project (Research study, appropriate for
patients with all solid tumors.)
-
(179-17) Pilot program to assess the potential role of pharmacogenomics
to improve drug safety in patients with advanced cancer. (Clinical research
study, appropriate for patients with brain, breast, GI, lung or ovarian cancer.)
-
(187-17)
Phase 1 trial of ZW25 in patients with locally advanced (unresectable)
and/or metastatic HER2-expressing cancers (Phase 1 clinical trial, appropriate for patients with HER2 expressing cancers.)
-
(211-17) Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate
Hepatic Impairment Patients (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)